Adam Skarka
Univerzita Hradec Králové
H-index: 14
Europe-Czech Republic
Top articles of Adam Skarka
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Frentizole derivatives with mTOR inhibiting and senomorphic properties | Biomedicine & Pharmacotherapy | Zofia Chrienova David Rysanek Josef Novak Pavla Vasicova Patrik Oleksak | 2023/11/1 |
BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS | Biomedicine & Pharmacotherapy | Eliska Prchalova Martina Sukupova David Malinak Rudolf Andrys Ladislav Sivak | 2023/11/1 |
Development of Submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation | European Journal of Medicinal Chemistry | Ondrej Benek Michaela Vaskova Marketa Miskerikova Monika Schmidt Rudolf Andrys | 2023/10/5 |
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics | Frontiers in Aging Neuroscience | Zofia Chrienova David Rysanek Patrik Oleksak Dorota Stary Marek Bajda | 2022/12/6 |
Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma Cells | Cancers | Veronika Skarkova Barbora Vitovcova Petra Matouskova Monika Manethova Petra Kazimirova | 2022/10/20 |
89P The effect of flubendazole on temozolomide treatment in glioblastoma cell | Annals of Oncology | K Dvorakova B Vitovcova A Skarka K Caltová E Rudolf | 2022/10/1 |
Physiological and biochemical responses of Brassica napus L. cultivars exposed to Cd stress. | Plant, Soil & Environment | Martina Komárková Zuzana Kovalíková Jiří Šimek Adam Skarka Jiří Tůma | 2022/9/1 |
Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance … | Toxicology and Applied Pharmacology | Dimitrios Vagiannis Yu Zhang Youssif Budagaga Eva Novotna Adam Skarka | 2022/1/1 |
Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines | Human & Experimental Toxicology | Veronika Skarkova Adam Skarka Monika Manethova Afroditi A Stefanidi Emil Rudolf | 2021/12 |
Tepotinib inhibits several drug efflux transporters and biotransformation enzymes: the role in drug-drug interactions and targeting cytostatic resistance in vitro and ex vivo | International Journal of Molecular Sciences | Dimitrios Vagiannis Youssif Budagaga Anselm Morell Yu Zhang Eva Novotná | 2021/11/3 |
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates | Journal of Enzyme Inhibition and Medicinal Chemistry | Hyun Myung Lee Rudolf Andrys Jakub Jonczyk Kyuneun Kim Avinash G Vishakantegowda | 2021/1/1 |
Ensartinib (X-396) effectively modulates pharmacokinetic resistance mediated by ABCB1 and ABCG2 drug efflux transporters and CYP3A4 biotransformation enzyme | Cancers | Dimitrios Vagiannis Eva Novotna Adam Skarka Sarah Kammerer Jan-Heiner Küpper | 2020/3/28 |
